Bio-Techne Saham

Bio-Techne EV/Pendapatan

EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) dari Bio-Techne (TECH) pada 12 Agu 2026 adalah 7,84. Tahun sebelumnya, EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) adalah 8,23 — perubahan sebesar -4,79% (lebih rendah).

EV/Pendapatan

7,84

YoY

-4,79%

Terakhir Diperbarui:

EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) dari Bio-Techne adalah 2026 7,84 . EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) dari Bio-Techne adalah 2025 8,23 . Menurun -4,79% lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Bio-Techne Analisis saham

Apa yang dilakukan Bio-Techne? Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Bio-Techne

EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) Bio-Techne adalah 7,84 pada tahun 2026.

EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) dari Bio-Techne berubah dari 8,23 menjadi 7,84, mewakili perubahan -4,79%. Nilainya lebih rendah daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) Bio-Techne sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Rasio EV/Pendapatan membandingkan nilai perusahaan dengan total pendapatan. Rasio ini sangat berguna untuk menilai perusahaan pertumbuhan tinggi yang mungkin belum menguntungkan.

Untuk mengevaluasi EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan), sangat penting untuk membandingkannya dengan perusahaan sejenis di industri dan sektor yang sama. Di Eulerpool, Anda dapat menemukan perbandingan industri langsung untuk EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan).

Nilai '' yang 'baik' bervariasi menurut industri dan tahap perusahaan. Di Eulerpool, Anda dapat membandingkan Bio-Techne EV/Pendapatan (Nilai Perusahaan terhadap Pendapatan) dengan pesaing sektor dan rata-rata industri untuk menilai apakah menarik.

Access this data via the Eulerpool API

Penilaian — Bio-Techne

Semua Metrik Kunci — Bio-Techne